Elsemieke Te Linde1, Claudette J M van Roij2, Bjӧrn K I Meijers3,4, Henriette De Loor3,4, Roy P C Kessels2,5, Jack F M Wetzels1. 1. Department of Nephrology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. 2. Department of Medical Psychology, Radboud University Medical Center, Nijmegen, The Netherlands. 3. Department of Nephrology and Renal Transplantation, University Hospitals Leuven and Laboratory of Nephrology, Leuven, Belgium. 4. Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium. 5. Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
Abstract
Background: Cognitive functions are altered in patients with CKD. However, it is suggested that cognitive functions improve after kidney transplantation, at least partially. A possible cause for this improvement could be the reduction of uremic retention solutes after transplantation. This study assessed the association between the changes in uremic toxin concentration with the changes in cognitive function in patients after kidney transplantation. Methods: Ten recipients of kidney transplants were compared with 18 controls (nine patients on hemodialysis, and nine patients with CKD stage 4 or 5 [eGFR <30 ml/min per 1.73 m2] who were not on dialysis). An extensive neuropsychological assessment, covering the five major cognitive domains (i.e., memory, attention and concentration, information processing speed, abstract reasoning, and executive function), was done before transplantation, at 1 week post-transplant, and 3 months after transplantation. Similarly, assessments of the 18 matched, control patients were performed longitudinally over a period of 3-5 months. Concentrations of 16 uremic retention solutes (indoxyl glucuronide, p-cresyl glucuronide, phenylglucuronide, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, indoxyl sulfate, p-cresyl sulfate, hippuric acid, phenyl sulfate, kynurenine, tryptophan, kynurenic acid, tyrosine, indole-3-acetic acid, phenylalanine, trimethylamine N-oxide, and phenylacetylglutamine) were measured in serum samples collected at the time of the neuropsychological assessments. Results: A significant improvement in cognitive function was only found in the processing-speed domain, and this was observed in both patients who received a transplant and patients with CKD. No significant differences between patients who received a transplant and the control groups were seen in the other cognitive domains. As expected, the serum concentration of most uremic toxins decreased significantly within 1 week after kidney transplantation. Conclusions: There was no significant improvement in cognitive function that could be specifically related to kidney transplantation in the first 3 months after the procedure. These data do not support the notion that uremic toxins exert an immediate effect on cognitive function.
Background: Cognitive functions are altered in patients with CKD. However, it is suggested that cognitive functions improve after kidney transplantation, at least partially. A possible cause for this improvement could be the reduction of uremic retention solutes after transplantation. This study assessed the association between the changes in uremic toxin concentration with the changes in cognitive function in patients after kidney transplantation. Methods: Ten recipients of kidney transplants were compared with 18 controls (nine patients on hemodialysis, and nine patients with CKD stage 4 or 5 [eGFR <30 ml/min per 1.73 m2] who were not on dialysis). An extensive neuropsychological assessment, covering the five major cognitive domains (i.e., memory, attention and concentration, information processing speed, abstract reasoning, and executive function), was done before transplantation, at 1 week post-transplant, and 3 months after transplantation. Similarly, assessments of the 18 matched, control patients were performed longitudinally over a period of 3-5 months. Concentrations of 16 uremic retention solutes (indoxyl glucuronide, p-cresyl glucuronide, phenylglucuronide, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, indoxyl sulfate, p-cresyl sulfate, hippuric acid, phenyl sulfate, kynurenine, tryptophan, kynurenic acid, tyrosine, indole-3-acetic acid, phenylalanine, trimethylamine N-oxide, and phenylacetylglutamine) were measured in serum samples collected at the time of the neuropsychological assessments. Results: A significant improvement in cognitive function was only found in the processing-speed domain, and this was observed in both patients who received a transplant and patients with CKD. No significant differences between patients who received a transplant and the control groups were seen in the other cognitive domains. As expected, the serum concentration of most uremic toxins decreased significantly within 1 week after kidney transplantation. Conclusions: There was no significant improvement in cognitive function that could be specifically related to kidney transplantation in the first 3 months after the procedure. These data do not support the notion that uremic toxins exert an immediate effect on cognitive function.
Authors: E van den Berg; R P C Kessels; E H F de Haan; L J Kappelle; G J Biessels Journal: J Neurol Neurosurg Psychiatry Date: 2005-10 Impact factor: 10.154
Authors: Mark J Sarnak; Hocine Tighiouart; Tammy M Scott; Kristina V Lou; Eric P Sorensen; Lena M Giang; David A Drew; Kamran Shaffi; James A Strom; Ajay K Singh; Daniel E Weiner Journal: Neurology Date: 2013-01-09 Impact factor: 9.910
Authors: Anne M Murray; Elizabeth J Bell; David E Tupper; Cynthia S Davey; Sarah L Pederson; Elizabeth M Amiot; Kathleen M Miley; Lauren McPherson; Brooke M Heubner; David T Gilbertson; Robert N Foley; Paul E Drawz; Yelena Slinin; Rebecca C Rossom; Kamakshi Lakshminarayan; Prashanthi Vemuri; Clifford R Jack; David S Knopman Journal: Am J Kidney Dis Date: 2015-12-29 Impact factor: 8.860
Authors: Sophie Liabeuf; Lucie Desjardins; Ziad A Massy; François Brazier; Pierre François Westeel; Hakim Mazouz; Dimitri Titeca-Beauport; Momar Diouf; Griet Glorieux; Raymond Vanholder; Maité Jaureguy; Gabriel Choukroun Journal: Circ J Date: 2016-02-04 Impact factor: 2.993
Authors: Piotr K Krajewski; Kinga Tyczyńska; Klaudia Bardowska; Piotr Olczyk; Magdalena Krajewska; Jacek C Szepietowski Journal: Toxins (Basel) Date: 2022-04-30 Impact factor: 5.075